Literature DB >> 30348659

The End of the Binary Era: Revisiting the Spectrum of Tuberculosis.

Philana Ling Lin1, JoAnne L Flynn2.   

Abstract

Human Mycobacterium tuberculosis infection was thought to result in either active symptomatic tuberculosis (TB) or latent asymptomatic infection. It is now clear that this binary classification is insufficient to describe the myriad of infection outcomes. In active TB, symptomatic disease can be mild to severe, with a range of lung and thoracic lymph node involvement or extrapulmonary manifestations. Most humans control the infection and develop latent TB infection, with differential risks of reactivation to active TB. However, some frequently exposed persons appear to be resistant to infection, whereas others may initially become infected yet subsequently eliminate all bacilli. The immunologic factors influencing these varied outcomes are still not clear, but likely involve a range of different responses. In this article, we review the data supporting the spectrum of M. tuberculosis infection in humans as well as data in nonhuman primates that allow dissection of the immune responses leading to the varied outcomes of infection.
Copyright © 2018 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30348659      PMCID: PMC6217958          DOI: 10.4049/jimmunol.1800993

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  54 in total

1.  Resistance and Susceptibility to Mycobacterium tuberculosis Infection and Disease in Tuberculosis Households in Kampala, Uganda.

Authors:  Catherine M Stein; Sarah Zalwango; LaShaunda L Malone; Bonnie Thiel; Ezekiel Mupere; Mary Nsereko; Brenda Okware; Hussein Kisingo; Christina L Lancioni; Charles M Bark; Christopher C Whalen; Moses L Joloba; W Henry Boom; Harriet Mayanja-Kizza
Journal:  Am J Epidemiol       Date:  2018-07-01       Impact factor: 4.897

2.  Genome-wide expression for diagnosis of pulmonary tuberculosis: a multicohort analysis.

Authors:  Timothy E Sweeney; Lindsay Braviak; Cristina M Tato; Purvesh Khatri
Journal:  Lancet Respir Med       Date:  2016-02-20       Impact factor: 30.700

Review 3.  Tuberculosis.

Authors:  Alimuddin Zumla; Mario Raviglione; Richard Hafner; C Fordham von Reyn
Journal:  N Engl J Med       Date:  2013-02-21       Impact factor: 91.245

4.  Spread of tuberculosis via recirculated air in a naval vessel: the Byrd study.

Authors:  V N Houk
Journal:  Ann N Y Acad Sci       Date:  1980       Impact factor: 5.691

Review 5.  Understanding latent tuberculosis: a moving target.

Authors:  Philana Ling Lin; Joanne L Flynn
Journal:  J Immunol       Date:  2010-07-01       Impact factor: 5.422

Review 6.  Tuberculosis and latent tuberculosis infection in close contacts of people with pulmonary tuberculosis in low-income and middle-income countries: a systematic review and meta-analysis.

Authors:  Janina Morrison; Madhukar Pai; Philip C Hopewell
Journal:  Lancet Infect Dis       Date:  2008-04-29       Impact factor: 25.071

7.  Diversity of Human and Macaque Airway Immune Cells at Baseline and during Tuberculosis Infection.

Authors:  Richard F Silver; Amy J Myers; Jessica Jarvela; JoAnne Flynn; Tara Rutledge; Tracey Bonfield; Philana Ling Lin
Journal:  Am J Respir Cell Mol Biol       Date:  2016-12       Impact factor: 6.914

8.  Early Changes by (18)Fluorodeoxyglucose positron emission tomography coregistered with computed tomography predict outcome after Mycobacterium tuberculosis infection in cynomolgus macaques.

Authors:  M Teresa Coleman; Pauline Maiello; Jaime Tomko; Lonnie James Frye; Daniel Fillmore; Christopher Janssen; Edwin Klein; Philana Ling Lin
Journal:  Infect Immun       Date:  2014-03-24       Impact factor: 3.441

9.  An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis.

Authors:  Matthew P R Berry; Christine M Graham; Finlay W McNab; Zhaohui Xu; Susannah A A Bloch; Tolu Oni; Katalin A Wilkinson; Romain Banchereau; Jason Skinner; Robert J Wilkinson; Charles Quinn; Derek Blankenship; Ranju Dhawan; John J Cush; Asuncion Mejias; Octavio Ramilo; Onn M Kon; Virginia Pascual; Jacques Banchereau; Damien Chaussabel; Anne O'Garra
Journal:  Nature       Date:  2010-08-19       Impact factor: 49.962

10.  PET CT Identifies Reactivation Risk in Cynomolgus Macaques with Latent M. tuberculosis.

Authors:  Philana Ling Lin; Pauline Maiello; Hannah P Gideon; M Teresa Coleman; Anthony M Cadena; Mark A Rodgers; Robert Gregg; Melanie O'Malley; Jaime Tomko; Daniel Fillmore; L James Frye; Tara Rutledge; Robert M DiFazio; Christopher Janssen; Edwin Klein; Peter L Andersen; Sarah M Fortune; JoAnne L Flynn
Journal:  PLoS Pathog       Date:  2016-07-05       Impact factor: 6.823

View more
  33 in total

1.  Pulmonary Mycobacterium tuberculosis control associates with CXCR3- and CCR6-expressing antigen-specific Th1 and Th17 cell recruitment.

Authors:  Uma Shanmugasundaram; Allison N Bucsan; Shashank R Ganatra; Chris Ibegbu; Melanie Quezada; Robert V Blair; Xavier Alvarez; Vijayakumar Velu; Deepak Kaushal; Jyothi Rengarajan
Journal:  JCI Insight       Date:  2020-07-23

2.  l-Arginine Synthesis from l-Citrulline in Myeloid Cells Drives Host Defense against Mycobacteria In Vivo.

Authors:  Shannon M Lange; Melanie C McKell; Stephanie M Schmidt; Junfang Zhao; Rebecca R Crowther; Lisa C Green; Rebecca L Bricker; Eusondia Arnett; S Eleonore Köhler; Larry S Schlesinger; Kenneth D R Setchell; Joseph E Qualls
Journal:  J Immunol       Date:  2019-02-01       Impact factor: 5.422

3.  γ-herpesvirus latency attenuates Mycobacterium tuberculosis infection in mice.

Authors:  Halli E Miller; Kaitlin E Johnson; Vera L Tarakanova; Richard T Robinson
Journal:  Tuberculosis (Edinb)       Date:  2019-04-30       Impact factor: 3.131

Review 4.  TLRs in Mycobacterial Pathogenesis: Black and White or Shades of Gray.

Authors:  Priyanka Mehta; Atish Ray; Shibnath Mazumder
Journal:  Curr Microbiol       Date:  2021-04-12       Impact factor: 2.188

Review 5.  The knowns and unknowns of latent Mycobacterium tuberculosis infection.

Authors:  W Henry Boom; Ulrich E Schaible; Jacqueline M Achkar
Journal:  J Clin Invest       Date:  2021-02-01       Impact factor: 14.808

6.  Self-clearance of Mycobacterium tuberculosis infection: implications for lifetime risk and population at-risk of tuberculosis disease.

Authors:  Jon C Emery; Alexandra S Richards; Katie D Dale; C Finn McQuaid; Richard G White; Justin T Denholm; Rein M G J Houben
Journal:  Proc Biol Sci       Date:  2021-01-20       Impact factor: 5.349

7.  Isoniazid and Rifapentine Treatment Eradicates Persistent Mycobacterium tuberculosis in Macaques.

Authors:  Taylor W Foreman; Allison N Bucşan; Smriti Mehra; Charles Peloquin; Lara A Doyle; Kasi Russell-Lodrigue; Neel R Gandhi; John Altman; Cheryl L Day; Joel D Ernst; Henry M Blumberg; Jyothi Rengarajan; Deepak Kaushal
Journal:  Am J Respir Crit Care Med       Date:  2020-02-15       Impact factor: 30.528

Review 8.  Bacteria- and host-derived extracellular vesicles - two sides of the same coin?

Authors:  Jeffrey S Schorey; Yong Cheng; William R McManus
Journal:  J Cell Sci       Date:  2021-06-03       Impact factor: 5.235

9.  The immune landscape in tuberculosis reveals populations linked to disease and latency.

Authors:  Ekaterina Esaulova; Shibali Das; Dhiraj Kumar Singh; Jose Alberto Choreño-Parra; Amanda Swain; Laura Arthur; Javier Rangel-Moreno; Mushtaq Ahmed; Bindu Singh; Ananya Gupta; Luis Alejandro Fernández-López; Maria de la Luz Garcia-Hernandez; Allison Bucsan; Chivonne Moodley; Smriti Mehra; Ethel García-Latorre; Joaquin Zuniga; Jeffrey Atkinson; Deepak Kaushal; Maxim N Artyomov; Shabaana A Khader
Journal:  Cell Host Microbe       Date:  2020-12-18       Impact factor: 31.316

10.  Enhanced Human Immunodeficiency Virus-1 Replication in CD4+ T Cells Derived From Individuals With Latent Mycobacterium tuberculosis Infection.

Authors:  Xianbao He; Jared J Eddy; Karen R Jacobson; Andrew J Henderson; Luis M Agosto
Journal:  J Infect Dis       Date:  2020-10-01       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.